Review
doi: 10.12968/hmed.2007.68.2.22826.
Clinical evaluation of vaccines for pandemic influenza H5N1
Affiliations
- PMID: 17370705
- DOI: 10.12968/hmed.2007.68.2.22826
Item in Clipboard
Review
Clinical evaluation of vaccines for pandemic influenza H5N1
Br J Hosp Med (Lond).
2007 Feb.
Abstract
Avian influenza (H5N1) was first associated with human respiratory disease in Hong Kong in 1997. In 2004 the virus re-emerged among poultry and migratory birds in Asia and has spread into Europe and Africa, raising concerns that an H5 pandemic is imminent.
Similar articles
-
Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Expert Rev Vaccines. 2007 Apr;6(2):193-201. doi: 10.1586/14760584.6.2.193. Expert Rev Vaccines. 2007. PMID: 17408369 Review.
-
Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?Comp Immunol Microbiol Infect Dis. 2009 Jul;32(4):287-300. doi: 10.1016/j.cimid.2008.01.003. Comp Immunol Microbiol Infect Dis. 2009. PMID: 19318178 Review.
-
Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.Vaccine. 2013 Aug 2;31(35):3536-42. doi: 10.1016/j.vaccine.2013.05.076. Epub 2013 Jun 19. Vaccine. 2013. PMID: 23791547
-
Aflunov(®): a prepandemic influenza vaccine.Expert Rev Vaccines. 2012 Feb;11(2):145-57. doi: 10.1586/erv.11.170. Expert Rev Vaccines. 2012. PMID: 22309663 Review.
-
Strategies for developing vaccines against H5N1 influenza A viruses.Trends Mol Med. 2006 Nov;12(11):506-14. doi: 10.1016/j.molmed.2006.09.003. Epub 2006 Sep 29. Trends Mol Med. 2006. PMID: 17011235 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
